TY - JOUR
T1 - COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases
AU - Valdebenito, Silvana
AU - Bessis, Simon
AU - Annane, Djillali
AU - Lorin de la Grandmaison, Geoffroy
AU - Cramer–Bordé, Elisabeth
AU - Prideaux, Brendan
AU - Eugenin, Eliseo A.
AU - Bomsel, Morgane
N1 - Publisher Copyright:
© Copyright © 2021 Valdebenito, Bessis, Annane, Lorin de la Grandmaison, Cramer–Bordé, Prideaux, Eugenin and Bomsel.
PY - 2021/10/4
Y1 - 2021/10/4
N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health issue. COVID-19 is considered an airway/multi-systemic disease, and demise has been associated with an uncontrolled immune response and a cytokine storm in response to the virus. However, the lung pathology, immune response, and tissue damage associated with COVID-19 demise are poorly described and understood due to safety concerns. Using post-mortem lung tissues from uninfected and COVID-19 deadly cases as well as an unbiased combined analysis of histology, multi-viral and host markers staining, correlative microscopy, confocal, and image analysis, we identified three distinct phenotypes of COVID-19-induced lung damage. First, a COVID-19-induced hemorrhage characterized by minimal immune infiltration and large thrombus; Second, a COVID-19-induced immune infiltration with excessive immune cell infiltration but no hemorrhagic events. The third phenotype correspond to the combination of the two previous ones. We observed the loss of alveolar wall integrity, detachment of lung tissue pieces, fibroblast proliferation, and extensive fibrosis in all three phenotypes. Although lung tissues studied were from lethal COVID-19, a strong immune response was observed in all cases analyzed with significant B cell and poor T cell infiltrations, suggesting an exhausted or compromised immune cellular response in these patients. Overall, our data show that SARS-CoV-2-induced lung damage is highly heterogeneous. These individual differences need to be considered to understand the acute and long-term COVID-19 consequences.
AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health issue. COVID-19 is considered an airway/multi-systemic disease, and demise has been associated with an uncontrolled immune response and a cytokine storm in response to the virus. However, the lung pathology, immune response, and tissue damage associated with COVID-19 demise are poorly described and understood due to safety concerns. Using post-mortem lung tissues from uninfected and COVID-19 deadly cases as well as an unbiased combined analysis of histology, multi-viral and host markers staining, correlative microscopy, confocal, and image analysis, we identified three distinct phenotypes of COVID-19-induced lung damage. First, a COVID-19-induced hemorrhage characterized by minimal immune infiltration and large thrombus; Second, a COVID-19-induced immune infiltration with excessive immune cell infiltration but no hemorrhagic events. The third phenotype correspond to the combination of the two previous ones. We observed the loss of alveolar wall integrity, detachment of lung tissue pieces, fibroblast proliferation, and extensive fibrosis in all three phenotypes. Although lung tissues studied were from lethal COVID-19, a strong immune response was observed in all cases analyzed with significant B cell and poor T cell infiltrations, suggesting an exhausted or compromised immune cellular response in these patients. Overall, our data show that SARS-CoV-2-induced lung damage is highly heterogeneous. These individual differences need to be considered to understand the acute and long-term COVID-19 consequences.
KW - COVID-19
KW - SARS – CoV – 2
KW - immune
KW - immune activation
KW - lung
UR - http://www.scopus.com/inward/record.url?scp=85117218819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117218819&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.735922
DO - 10.3389/fimmu.2021.735922
M3 - Article
C2 - 34671353
AN - SCOPUS:85117218819
SN - 1664-3224
VL - 12
JO - Frontiers in immunology
JF - Frontiers in immunology
M1 - 735922
ER -